nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxazosin—Prazosin—hypertension	0.17	0.5	CrCtD
Doxazosin—Terazosin—hypertension	0.17	0.5	CrCtD
Doxazosin—ADRA1A—hypertension	0.0628	0.586	CbGaD
Doxazosin—Alfuzosin—Terazosin—hypertension	0.0471	0.217	CrCrCtD
Doxazosin—Prazosin—Terazosin—hypertension	0.0471	0.217	CrCrCtD
Doxazosin—Terazosin—Prazosin—hypertension	0.0471	0.217	CrCrCtD
Doxazosin—Alfuzosin—Prazosin—hypertension	0.0471	0.217	CrCrCtD
Doxazosin—ADRA2A—hypertension	0.0444	0.414	CbGaD
Doxazosin—Donepezil—Moexipril—hypertension	0.0291	0.134	CrCrCtD
Doxazosin—KCNH6—Terazosin—hypertension	0.0212	0.0964	CbGbCtD
Doxazosin—KCNH7—Terazosin—hypertension	0.0212	0.0964	CbGbCtD
Doxazosin—KCNH6—Prazosin—hypertension	0.0146	0.0661	CbGbCtD
Doxazosin—KCNH7—Prazosin—hypertension	0.0146	0.0661	CbGbCtD
Doxazosin—ADRA1D—Terazosin—hypertension	0.00538	0.0244	CbGbCtD
Doxazosin—ADRA1D—Fenoldopam—hypertension	0.00486	0.0221	CbGbCtD
Doxazosin—KCNH2—Terazosin—hypertension	0.00455	0.0207	CbGbCtD
Doxazosin—ORM1—Penbutolol—hypertension	0.00448	0.0203	CbGbCtD
Doxazosin—ADRA2A—Methyldopa—hypertension	0.00403	0.0183	CbGbCtD
Doxazosin—ADRA1B—Terazosin—hypertension	0.00391	0.0178	CbGbCtD
Doxazosin—ADRA1D—Prazosin—hypertension	0.00368	0.0167	CbGbCtD
Doxazosin—ADRA2A—Guanabenz—hypertension	0.00368	0.0167	CbGbCtD
Doxazosin—ORM1—Prazosin—hypertension	0.00354	0.0161	CbGbCtD
Doxazosin—ADRA1B—Fenoldopam—hypertension	0.00354	0.0161	CbGbCtD
Doxazosin—ADRA2A—Guanfacine—hypertension	0.00343	0.0156	CbGbCtD
Doxazosin—KCNH2—Bepridil—hypertension	0.00327	0.0149	CbGbCtD
Doxazosin—ADRA1D—Nicardipine—hypertension	0.00318	0.0144	CbGbCtD
Doxazosin—ADRA1D—Carvedilol—hypertension	0.00318	0.0144	CbGbCtD
Doxazosin—KCNH2—Prazosin—hypertension	0.00312	0.0142	CbGbCtD
Doxazosin—ADRA1A—Terazosin—hypertension	0.00309	0.014	CbGbCtD
Doxazosin—ADRA2A—Fenoldopam—hypertension	0.00291	0.0132	CbGbCtD
Doxazosin—ADRA1B—vas deferens—hypertension	0.00287	0.362	CbGeAlD
Doxazosin—ORM1—Propranolol—hypertension	0.00281	0.0128	CbGbCtD
Doxazosin—ADRA1A—Fenoldopam—hypertension	0.00279	0.0127	CbGbCtD
Doxazosin—ADRA1D—Clonidine—hypertension	0.00279	0.0127	CbGbCtD
Doxazosin—KCNH2—Carvedilol—hypertension	0.00269	0.0122	CbGbCtD
Doxazosin—ADRA1B—Prazosin—hypertension	0.00268	0.0122	CbGbCtD
Doxazosin—ADRA1B—Carvedilol—hypertension	0.00232	0.0105	CbGbCtD
Doxazosin—ADRA1B—Nicardipine—hypertension	0.00232	0.0105	CbGbCtD
Doxazosin—ADRA2A—Prazosin—hypertension	0.00221	0.01	CbGbCtD
Doxazosin—ADRA1A—Prazosin—hypertension	0.00212	0.00961	CbGbCtD
Doxazosin—ADRA1B—Clonidine—hypertension	0.00203	0.00923	CbGbCtD
Doxazosin—ADRA2A—Carvedilol—hypertension	0.00191	0.00865	CbGbCtD
Doxazosin—ADRA1A—Carvedilol—hypertension	0.00183	0.00829	CbGbCtD
Doxazosin—ADRA1A—Nicardipine—hypertension	0.00183	0.00829	CbGbCtD
Doxazosin—KCNH2—Verapamil—hypertension	0.0017	0.00772	CbGbCtD
Doxazosin—ADRA2A—Clonidine—hypertension	0.00167	0.00759	CbGbCtD
Doxazosin—CYP2C19—Torasemide—hypertension	0.00161	0.00732	CbGbCtD
Doxazosin—ADRA1A—Clonidine—hypertension	0.0016	0.00728	CbGbCtD
Doxazosin—CYP2C19—Guanfacine—hypertension	0.0015	0.0068	CbGbCtD
Doxazosin—CYP2C19—Metoprolol—hypertension	0.0015	0.0068	CbGbCtD
Doxazosin—ABCB1—Nadolol—hypertension	0.00142	0.00646	CbGbCtD
Doxazosin—CYP2D6—Nebivolol—hypertension	0.00134	0.00608	CbGbCtD
Doxazosin—CYP2D6—Labetalol—hypertension	0.00134	0.00608	CbGbCtD
Doxazosin—ABCB1—Acebutolol—hypertension	0.0013	0.0059	CbGbCtD
Doxazosin—CYP2D6—Acebutolol—hypertension	0.00123	0.00556	CbGbCtD
Doxazosin—ABCB1—Candesartan—hypertension	0.00121	0.00549	CbGbCtD
Doxazosin—ABCB1—Metoprolol—hypertension	0.00121	0.00549	CbGbCtD
Doxazosin—CYP2D6—Pindolol—hypertension	0.00114	0.00517	CbGbCtD
Doxazosin—CYP2D6—Metoprolol—hypertension	0.00114	0.00517	CbGbCtD
Doxazosin—ABCB1—Terazosin—hypertension	0.00114	0.00516	CbGbCtD
Doxazosin—CYP2C19—Diltiazem—hypertension	0.00114	0.00516	CbGbCtD
Doxazosin—ABCB1—Reserpine—hypertension	0.00108	0.00489	CbGbCtD
Doxazosin—CYP2C19—Telmisartan—hypertension	0.00107	0.00485	CbGbCtD
Doxazosin—CYP2D6—Betaxolol—hypertension	0.00102	0.00461	CbGbCtD
Doxazosin—ABCB1—Perindopril—hypertension	0.000986	0.00447	CbGbCtD
Doxazosin—ABCB1—Nisoldipine—hypertension	0.000949	0.00431	CbGbCtD
Doxazosin—ABCB1—Diltiazem—hypertension	0.000916	0.00416	CbGbCtD
Doxazosin—CYP2D6—Diltiazem—hypertension	0.000863	0.00392	CbGbCtD
Doxazosin—ABCB1—Telmisartan—hypertension	0.000861	0.00391	CbGbCtD
Doxazosin—CYP2C19—Timolol—hypertension	0.000861	0.00391	CbGbCtD
Doxazosin—CYP2C19—Nicardipine—hypertension	0.000833	0.00378	CbGbCtD
Doxazosin—ABCB1—Enalapril—hypertension	0.000817	0.00371	CbGbCtD
Doxazosin—ABCB1—Bepridil—hypertension	0.000817	0.00371	CbGbCtD
Doxazosin—ABCB1—Lisinopril—hypertension	0.000817	0.00371	CbGbCtD
Doxazosin—ABCB1—Prazosin—hypertension	0.000779	0.00354	CbGbCtD
Doxazosin—CYP2D6—Bepridil—hypertension	0.000769	0.00349	CbGbCtD
Doxazosin—CYP2C19—Propranolol—hypertension	0.000767	0.00348	CbGbCtD
Doxazosin—ABCB1—Amlodipine—hypertension	0.000732	0.00333	CbGbCtD
Doxazosin—ABCB1—Spironolactone—hypertension	0.000719	0.00326	CbGbCtD
Doxazosin—ABCB1—Felodipine—hypertension	0.000706	0.00321	CbGbCtD
Doxazosin—CYP2D6—Irbesartan—hypertension	0.000704	0.0032	CbGbCtD
Doxazosin—ABCB1—Timolol—hypertension	0.000694	0.00315	CbGbCtD
Doxazosin—CYP2D6—Amlodipine—hypertension	0.00069	0.00313	CbGbCtD
Doxazosin—ABCB1—Nifedipine—hypertension	0.000683	0.0031	CbGbCtD
Doxazosin—ABCB1—Carvedilol—hypertension	0.000672	0.00305	CbGbCtD
Doxazosin—ABCB1—Nicardipine—hypertension	0.000672	0.00305	CbGbCtD
Doxazosin—CYP2D6—Felodipine—hypertension	0.000665	0.00302	CbGbCtD
Doxazosin—CYP2D6—Timolol—hypertension	0.000654	0.00297	CbGbCtD
Doxazosin—CYP2C19—Atorvastatin—hypertension	0.000652	0.00296	CbGbCtD
Doxazosin—CYP2D6—Nifedipine—hypertension	0.000644	0.00292	CbGbCtD
Doxazosin—CYP2D6—Nicardipine—hypertension	0.000634	0.00288	CbGbCtD
Doxazosin—CYP2D6—Carvedilol—hypertension	0.000634	0.00288	CbGbCtD
Doxazosin—ABCB1—Propranolol—hypertension	0.000619	0.00281	CbGbCtD
Doxazosin—ABCB1—Captopril—hypertension	0.000611	0.00278	CbGbCtD
Doxazosin—CYP2C19—Losartan—hypertension	0.000597	0.00271	CbGbCtD
Doxazosin—ABCB1—Clonidine—hypertension	0.00059	0.00268	CbGbCtD
Doxazosin—CYP2D6—Propranolol—hypertension	0.000583	0.00265	CbGbCtD
Doxazosin—CYP2D6—Captopril—hypertension	0.000576	0.00262	CbGbCtD
Doxazosin—CYP2D6—Clonidine—hypertension	0.000556	0.00253	CbGbCtD
Doxazosin—CYP2C19—Verapamil—hypertension	0.000526	0.00239	CbGbCtD
Doxazosin—ABCB1—Atorvastatin—hypertension	0.000526	0.00239	CbGbCtD
Doxazosin—CYP2D6—Atorvastatin—hypertension	0.000496	0.00225	CbGbCtD
Doxazosin—ABCB1—Losartan—hypertension	0.000481	0.00219	CbGbCtD
Doxazosin—ABCB1—Verapamil—hypertension	0.000425	0.00193	CbGbCtD
Doxazosin—CYP2C19—urine—hypertension	0.000405	0.0512	CbGeAlD
Doxazosin—CYP2D6—Verapamil—hypertension	0.0004	0.00182	CbGbCtD
Doxazosin—KCNH6—nephron tubule—hypertension	0.000339	0.0428	CbGeAlD
Doxazosin—Donepezil—HRH3—hypertension	0.000328	0.26	CrCbGaD
Doxazosin—KCNH6—kidney—hypertension	0.000298	0.0376	CbGeAlD
Doxazosin—KCNH7—central nervous system—hypertension	0.000264	0.0333	CbGeAlD
Doxazosin—CYP2D6—urine—hypertension	0.000236	0.0298	CbGeAlD
Doxazosin—Alfuzosin—ADRA1A—hypertension	0.000206	0.163	CrCbGaD
Doxazosin—Prazosin—ADRA2B—hypertension	0.000199	0.158	CrCbGaD
Doxazosin—KCNH6—central nervous system—hypertension	0.000188	0.0237	CbGeAlD
Doxazosin—Terazosin—ADRA1A—hypertension	0.00018	0.143	CrCbGaD
Doxazosin—ADRA1B—kidney—hypertension	0.000169	0.0213	CbGeAlD
Doxazosin—KCNH2—cardiac ventricle—hypertension	0.000151	0.0191	CbGeAlD
Doxazosin—KCNH2—myocardium—hypertension	0.000142	0.0179	CbGeAlD
Doxazosin—Prazosin—ADRA1A—hypertension	0.000123	0.0978	CrCbGaD
Doxazosin—ADRA1A—brainstem—hypertension	0.000119	0.015	CbGeAlD
Doxazosin—ADRA1D—endocrine gland—hypertension	0.000116	0.0146	CbGeAlD
Doxazosin—ADRA1B—central nervous system—hypertension	0.000107	0.0134	CbGeAlD
Doxazosin—ADRA1D—central nervous system—hypertension	0.000104	0.0132	CbGeAlD
Doxazosin—ADRA1A—heart—hypertension	0.000103	0.013	CbGeAlD
Doxazosin—KCNH2—heart—hypertension	9.91e-05	0.0125	CbGeAlD
Doxazosin—ADRA1A—cardiovascular system—hypertension	9.68e-05	0.0122	CbGeAlD
Doxazosin—ORM1—endocrine gland—hypertension	9.52e-05	0.012	CbGeAlD
Doxazosin—KCNH2—cardiovascular system—hypertension	9.35e-05	0.0118	CbGeAlD
Doxazosin—ABCB1—blood vessel—hypertension	9.19e-05	0.0116	CbGeAlD
Doxazosin—Prazosin—ADRA2A—hypertension	8.74e-05	0.0693	CrCbGaD
Doxazosin—ORM1—central nervous system—hypertension	8.58e-05	0.0108	CbGeAlD
Doxazosin—KCNH2—cardiac atrium—hypertension	8.48e-05	0.0107	CbGeAlD
Doxazosin—KCNH2—medulla oblongata—hypertension	7.99e-05	0.0101	CbGeAlD
Doxazosin—ADRA2A—heart—hypertension	7.8e-05	0.00985	CbGeAlD
Doxazosin—ADRA1A—adrenal gland—hypertension	7.66e-05	0.00967	CbGeAlD
Doxazosin—ADRA2A—decidua—hypertension	7.59e-05	0.00958	CbGeAlD
Doxazosin—Donepezil—HTR2A—hypertension	7.48e-05	0.0592	CrCbGaD
Doxazosin—KCNH2—adrenal gland—hypertension	7.4e-05	0.00934	CbGeAlD
Doxazosin—ADRA2A—cortex of kidney—hypertension	7.01e-05	0.00885	CbGeAlD
Doxazosin—CYP2D6—brainstem—hypertension	6.99e-05	0.00882	CbGeAlD
Doxazosin—CYP2C19—endocrine gland—hypertension	6.72e-05	0.00849	CbGeAlD
Doxazosin—ADRA2A—cardiac atrium—hypertension	6.67e-05	0.00842	CbGeAlD
Doxazosin—ADRA1A—endocrine gland—hypertension	6.64e-05	0.00838	CbGeAlD
Doxazosin—KCNH2—endocrine gland—hypertension	6.41e-05	0.0081	CbGeAlD
Doxazosin—Prazosin—CYP1A1—hypertension	6.3e-05	0.0499	CrCbGaD
Doxazosin—ADRA2A—medulla oblongata—hypertension	6.29e-05	0.00794	CbGeAlD
Doxazosin—ADRA1A—central nervous system—hypertension	5.98e-05	0.00755	CbGeAlD
Doxazosin—ADRA2A—adrenal gland—hypertension	5.82e-05	0.00735	CbGeAlD
Doxazosin—KCNH2—central nervous system—hypertension	5.78e-05	0.00729	CbGeAlD
Doxazosin—CYP2D6—kidney—hypertension	5.58e-05	0.00704	CbGeAlD
Doxazosin—ADRA2A—endocrine gland—hypertension	5.05e-05	0.00637	CbGeAlD
Doxazosin—ABCB1—nephron tubule—hypertension	4.57e-05	0.00576	CbGeAlD
Doxazosin—ADRA2A—central nervous system—hypertension	4.55e-05	0.00574	CbGeAlD
Doxazosin—ABCB1—adrenal cortex—hypertension	4.49e-05	0.00567	CbGeAlD
Doxazosin—ABCB1—heart—hypertension	4.35e-05	0.00549	CbGeAlD
Doxazosin—ABCB1—decidua—hypertension	4.23e-05	0.00534	CbGeAlD
Doxazosin—ABCB1—cardiovascular system—hypertension	4.1e-05	0.00518	CbGeAlD
Doxazosin—ABCB1—kidney—hypertension	4.01e-05	0.00507	CbGeAlD
Doxazosin—CYP2D6—endocrine gland—hypertension	3.91e-05	0.00494	CbGeAlD
Doxazosin—ABCB1—cortex of kidney—hypertension	3.91e-05	0.00493	CbGeAlD
Doxazosin—CYP2D6—central nervous system—hypertension	3.52e-05	0.00445	CbGeAlD
Doxazosin—ABCB1—medulla oblongata—hypertension	3.5e-05	0.00442	CbGeAlD
Doxazosin—ABCB1—adrenal gland—hypertension	3.24e-05	0.0041	CbGeAlD
Doxazosin—ABCB1—endocrine gland—hypertension	2.81e-05	0.00355	CbGeAlD
Doxazosin—ABCB1—central nervous system—hypertension	2.54e-05	0.0032	CbGeAlD
Doxazosin—Diarrhoea—Olmesartan—hypertension	5.35e-06	7.36e-05	CcSEcCtD
Doxazosin—Headache—Eplerenone—hypertension	5.35e-06	7.36e-05	CcSEcCtD
Doxazosin—Rash—Nifedipine—hypertension	5.34e-06	7.35e-05	CcSEcCtD
Doxazosin—Dermatitis—Nifedipine—hypertension	5.34e-06	7.34e-05	CcSEcCtD
Doxazosin—Body temperature increased—Irbesartan—hypertension	5.33e-06	7.34e-05	CcSEcCtD
Doxazosin—Abdominal pain—Irbesartan—hypertension	5.33e-06	7.34e-05	CcSEcCtD
Doxazosin—Thrombocytopenia—Ramipril—hypertension	5.33e-06	7.34e-05	CcSEcCtD
Doxazosin—Oedema—Timolol—hypertension	5.32e-06	7.33e-05	CcSEcCtD
Doxazosin—Loss of consciousness—Lisinopril—hypertension	5.32e-06	7.32e-05	CcSEcCtD
Doxazosin—Rash—Verapamil—hypertension	5.32e-06	7.32e-05	CcSEcCtD
Doxazosin—Urticaria—Hydrochlorothiazide—hypertension	5.32e-06	7.32e-05	CcSEcCtD
Doxazosin—Tachycardia—Ramipril—hypertension	5.31e-06	7.31e-05	CcSEcCtD
Doxazosin—Dermatitis—Verapamil—hypertension	5.31e-06	7.31e-05	CcSEcCtD
Doxazosin—Headache—Nifedipine—hypertension	5.31e-06	7.3e-05	CcSEcCtD
Doxazosin—Pruritus—Clonidine—hypertension	5.3e-06	7.29e-05	CcSEcCtD
Doxazosin—Abdominal pain—Hydrochlorothiazide—hypertension	5.29e-06	7.28e-05	CcSEcCtD
Doxazosin—Body temperature increased—Hydrochlorothiazide—hypertension	5.29e-06	7.28e-05	CcSEcCtD
Doxazosin—Skin disorder—Ramipril—hypertension	5.29e-06	7.28e-05	CcSEcCtD
Doxazosin—Infection—Timolol—hypertension	5.29e-06	7.28e-05	CcSEcCtD
Doxazosin—Headache—Verapamil—hypertension	5.28e-06	7.27e-05	CcSEcCtD
Doxazosin—Hypersensitivity—Telmisartan—hypertension	5.28e-06	7.27e-05	CcSEcCtD
Doxazosin—Cough—Lisinopril—hypertension	5.28e-06	7.27e-05	CcSEcCtD
Doxazosin—Nausea—Indapamide—hypertension	5.27e-06	7.26e-05	CcSEcCtD
Doxazosin—Nausea—Diltiazem—hypertension	5.27e-06	7.26e-05	CcSEcCtD
Doxazosin—Hyperhidrosis—Ramipril—hypertension	5.26e-06	7.25e-05	CcSEcCtD
Doxazosin—Asthenia—Trandolapril—hypertension	5.24e-06	7.21e-05	CcSEcCtD
Doxazosin—Shock—Timolol—hypertension	5.24e-06	7.21e-05	CcSEcCtD
Doxazosin—Feeling abnormal—Losartan—hypertension	5.23e-06	7.2e-05	CcSEcCtD
Doxazosin—Urticaria—Furosemide—hypertension	5.23e-06	7.2e-05	CcSEcCtD
Doxazosin—Nausea—Carvedilol—hypertension	5.22e-06	7.18e-05	CcSEcCtD
Doxazosin—Asthenia—Enalapril—hypertension	5.22e-06	7.18e-05	CcSEcCtD
Doxazosin—Abdominal pain—Furosemide—hypertension	5.2e-06	7.16e-05	CcSEcCtD
Doxazosin—Body temperature increased—Furosemide—hypertension	5.2e-06	7.16e-05	CcSEcCtD
Doxazosin—Gastrointestinal pain—Losartan—hypertension	5.19e-06	7.15e-05	CcSEcCtD
Doxazosin—Dizziness—Valsartan—hypertension	5.19e-06	7.15e-05	CcSEcCtD
Doxazosin—Anorexia—Ramipril—hypertension	5.19e-06	7.14e-05	CcSEcCtD
Doxazosin—Urticaria—Betaxolol—hypertension	5.18e-06	7.12e-05	CcSEcCtD
Doxazosin—Skin disorder—Timolol—hypertension	5.17e-06	7.12e-05	CcSEcCtD
Doxazosin—Dizziness—Olmesartan—hypertension	5.17e-06	7.11e-05	CcSEcCtD
Doxazosin—Pruritus—Trandolapril—hypertension	5.16e-06	7.11e-05	CcSEcCtD
Doxazosin—Arthralgia—Lisinopril—hypertension	5.15e-06	7.09e-05	CcSEcCtD
Doxazosin—Chest pain—Lisinopril—hypertension	5.15e-06	7.09e-05	CcSEcCtD
Doxazosin—Myalgia—Lisinopril—hypertension	5.15e-06	7.09e-05	CcSEcCtD
Doxazosin—Body temperature increased—Betaxolol—hypertension	5.15e-06	7.09e-05	CcSEcCtD
Doxazosin—Hyperhidrosis—Timolol—hypertension	5.15e-06	7.08e-05	CcSEcCtD
Doxazosin—Asthenia—Telmisartan—hypertension	5.14e-06	7.08e-05	CcSEcCtD
Doxazosin—Pruritus—Enalapril—hypertension	5.14e-06	7.08e-05	CcSEcCtD
Doxazosin—Anxiety—Lisinopril—hypertension	5.13e-06	7.07e-05	CcSEcCtD
Doxazosin—Diarrhoea—Clonidine—hypertension	5.12e-06	7.05e-05	CcSEcCtD
Doxazosin—Nausea—Fosinopril—hypertension	5.1e-06	7.02e-05	CcSEcCtD
Doxazosin—Discomfort—Lisinopril—hypertension	5.09e-06	7.01e-05	CcSEcCtD
Doxazosin—Hypotension—Ramipril—hypertension	5.09e-06	7e-05	CcSEcCtD
Doxazosin—Anorexia—Timolol—hypertension	5.07e-06	6.98e-05	CcSEcCtD
Doxazosin—Pruritus—Telmisartan—hypertension	5.07e-06	6.98e-05	CcSEcCtD
Doxazosin—Nausea—Eplerenone—hypertension	5.07e-06	6.98e-05	CcSEcCtD
Doxazosin—Urticaria—Losartan—hypertension	5.04e-06	6.94e-05	CcSEcCtD
Doxazosin—Dry mouth—Lisinopril—hypertension	5.04e-06	6.93e-05	CcSEcCtD
Doxazosin—Nausea—Nifedipine—hypertension	5.03e-06	6.93e-05	CcSEcCtD
Doxazosin—Abdominal pain—Losartan—hypertension	5.02e-06	6.91e-05	CcSEcCtD
Doxazosin—Body temperature increased—Losartan—hypertension	5.02e-06	6.91e-05	CcSEcCtD
Doxazosin—Nausea—Verapamil—hypertension	5.01e-06	6.89e-05	CcSEcCtD
Doxazosin—Asthenia—Captopril—hypertension	5e-06	6.89e-05	CcSEcCtD
Doxazosin—Diarrhoea—Trandolapril—hypertension	4.99e-06	6.87e-05	CcSEcCtD
Doxazosin—Vomiting—Valsartan—hypertension	4.99e-06	6.87e-05	CcSEcCtD
Doxazosin—Confusional state—Lisinopril—hypertension	4.98e-06	6.85e-05	CcSEcCtD
Doxazosin—Diarrhoea—Enalapril—hypertension	4.97e-06	6.85e-05	CcSEcCtD
Doxazosin—Hypotension—Timolol—hypertension	4.97e-06	6.85e-05	CcSEcCtD
Doxazosin—Hypersensitivity—Irbesartan—hypertension	4.97e-06	6.84e-05	CcSEcCtD
Doxazosin—Vomiting—Olmesartan—hypertension	4.97e-06	6.84e-05	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Ramipril—hypertension	4.96e-06	6.83e-05	CcSEcCtD
Doxazosin—Rash—Valsartan—hypertension	4.95e-06	6.81e-05	CcSEcCtD
Doxazosin—Dizziness—Clonidine—hypertension	4.95e-06	6.81e-05	CcSEcCtD
Doxazosin—Dermatitis—Valsartan—hypertension	4.95e-06	6.81e-05	CcSEcCtD
Doxazosin—Oedema—Lisinopril—hypertension	4.94e-06	6.8e-05	CcSEcCtD
Doxazosin—Pruritus—Captopril—hypertension	4.93e-06	6.79e-05	CcSEcCtD
Doxazosin—Hypersensitivity—Hydrochlorothiazide—hypertension	4.93e-06	6.79e-05	CcSEcCtD
Doxazosin—Rash—Olmesartan—hypertension	4.93e-06	6.78e-05	CcSEcCtD
Doxazosin—Insomnia—Ramipril—hypertension	4.92e-06	6.78e-05	CcSEcCtD
Doxazosin—Dermatitis—Olmesartan—hypertension	4.92e-06	6.78e-05	CcSEcCtD
Doxazosin—Headache—Valsartan—hypertension	4.92e-06	6.77e-05	CcSEcCtD
Doxazosin—Diarrhoea—Telmisartan—hypertension	4.91e-06	6.75e-05	CcSEcCtD
Doxazosin—Infection—Lisinopril—hypertension	4.91e-06	6.75e-05	CcSEcCtD
Doxazosin—Headache—Olmesartan—hypertension	4.9e-06	6.74e-05	CcSEcCtD
Doxazosin—Paraesthesia—Ramipril—hypertension	4.89e-06	6.73e-05	CcSEcCtD
Doxazosin—Shock—Lisinopril—hypertension	4.86e-06	6.69e-05	CcSEcCtD
Doxazosin—Asthenia—Perindopril—hypertension	4.86e-06	6.69e-05	CcSEcCtD
Doxazosin—Dyspnoea—Ramipril—hypertension	4.85e-06	6.68e-05	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Timolol—hypertension	4.85e-06	6.68e-05	CcSEcCtD
Doxazosin—Hypersensitivity—Furosemide—hypertension	4.85e-06	6.67e-05	CcSEcCtD
Doxazosin—Asthenia—Irbesartan—hypertension	4.84e-06	6.66e-05	CcSEcCtD
Doxazosin—Somnolence—Ramipril—hypertension	4.84e-06	6.66e-05	CcSEcCtD
Doxazosin—Thrombocytopenia—Lisinopril—hypertension	4.83e-06	6.65e-05	CcSEcCtD
Doxazosin—Dizziness—Trandolapril—hypertension	4.83e-06	6.64e-05	CcSEcCtD
Doxazosin—Tachycardia—Lisinopril—hypertension	4.82e-06	6.63e-05	CcSEcCtD
Doxazosin—Insomnia—Timolol—hypertension	4.81e-06	6.63e-05	CcSEcCtD
Doxazosin—Dizziness—Enalapril—hypertension	4.81e-06	6.62e-05	CcSEcCtD
Doxazosin—Asthenia—Hydrochlorothiazide—hypertension	4.8e-06	6.61e-05	CcSEcCtD
Doxazosin—Hypersensitivity—Betaxolol—hypertension	4.8e-06	6.61e-05	CcSEcCtD
Doxazosin—Skin disorder—Lisinopril—hypertension	4.8e-06	6.6e-05	CcSEcCtD
Doxazosin—Dyspepsia—Ramipril—hypertension	4.79e-06	6.6e-05	CcSEcCtD
Doxazosin—Pruritus—Perindopril—hypertension	4.79e-06	6.59e-05	CcSEcCtD
Doxazosin—Paraesthesia—Timolol—hypertension	4.78e-06	6.58e-05	CcSEcCtD
Doxazosin—Pruritus—Irbesartan—hypertension	4.77e-06	6.57e-05	CcSEcCtD
Doxazosin—Hyperhidrosis—Lisinopril—hypertension	4.77e-06	6.57e-05	CcSEcCtD
Doxazosin—Diarrhoea—Captopril—hypertension	4.77e-06	6.57e-05	CcSEcCtD
Doxazosin—Vomiting—Clonidine—hypertension	4.76e-06	6.55e-05	CcSEcCtD
Doxazosin—Dyspnoea—Timolol—hypertension	4.75e-06	6.53e-05	CcSEcCtD
Doxazosin—Dizziness—Telmisartan—hypertension	4.74e-06	6.53e-05	CcSEcCtD
Doxazosin—Pruritus—Hydrochlorothiazide—hypertension	4.73e-06	6.52e-05	CcSEcCtD
Doxazosin—Decreased appetite—Ramipril—hypertension	4.73e-06	6.51e-05	CcSEcCtD
Doxazosin—Somnolence—Timolol—hypertension	4.73e-06	6.51e-05	CcSEcCtD
Doxazosin—Asthenia—Furosemide—hypertension	4.72e-06	6.5e-05	CcSEcCtD
Doxazosin—Rash—Clonidine—hypertension	4.72e-06	6.5e-05	CcSEcCtD
Doxazosin—Dermatitis—Clonidine—hypertension	4.71e-06	6.49e-05	CcSEcCtD
Doxazosin—Anorexia—Lisinopril—hypertension	4.71e-06	6.48e-05	CcSEcCtD
Doxazosin—Fatigue—Ramipril—hypertension	4.69e-06	6.46e-05	CcSEcCtD
Doxazosin—Headache—Clonidine—hypertension	4.69e-06	6.45e-05	CcSEcCtD
Doxazosin—Dyspepsia—Timolol—hypertension	4.69e-06	6.45e-05	CcSEcCtD
Doxazosin—Hypersensitivity—Losartan—hypertension	4.68e-06	6.44e-05	CcSEcCtD
Doxazosin—Asthenia—Betaxolol—hypertension	4.67e-06	6.43e-05	CcSEcCtD
Doxazosin—Nausea—Valsartan—hypertension	4.66e-06	6.42e-05	CcSEcCtD
Doxazosin—Pruritus—Furosemide—hypertension	4.66e-06	6.41e-05	CcSEcCtD
Doxazosin—Constipation—Ramipril—hypertension	4.66e-06	6.41e-05	CcSEcCtD
Doxazosin—Nausea—Olmesartan—hypertension	4.64e-06	6.39e-05	CcSEcCtD
Doxazosin—Vomiting—Trandolapril—hypertension	4.64e-06	6.39e-05	CcSEcCtD
Doxazosin—Diarrhoea—Perindopril—hypertension	4.63e-06	6.38e-05	CcSEcCtD
Doxazosin—Decreased appetite—Timolol—hypertension	4.63e-06	6.37e-05	CcSEcCtD
Doxazosin—Vomiting—Enalapril—hypertension	4.62e-06	6.36e-05	CcSEcCtD
Doxazosin—Diarrhoea—Irbesartan—hypertension	4.62e-06	6.35e-05	CcSEcCtD
Doxazosin—Hypotension—Lisinopril—hypertension	4.61e-06	6.35e-05	CcSEcCtD
Doxazosin—Dizziness—Captopril—hypertension	4.61e-06	6.35e-05	CcSEcCtD
Doxazosin—Pruritus—Betaxolol—hypertension	4.61e-06	6.35e-05	CcSEcCtD
Doxazosin—Rash—Trandolapril—hypertension	4.6e-06	6.33e-05	CcSEcCtD
Doxazosin—Dermatitis—Trandolapril—hypertension	4.6e-06	6.33e-05	CcSEcCtD
Doxazosin—Fatigue—Timolol—hypertension	4.59e-06	6.32e-05	CcSEcCtD
Doxazosin—Rash—Enalapril—hypertension	4.58e-06	6.31e-05	CcSEcCtD
Doxazosin—Dermatitis—Enalapril—hypertension	4.58e-06	6.3e-05	CcSEcCtD
Doxazosin—Diarrhoea—Hydrochlorothiazide—hypertension	4.58e-06	6.3e-05	CcSEcCtD
Doxazosin—Headache—Trandolapril—hypertension	4.57e-06	6.29e-05	CcSEcCtD
Doxazosin—Vomiting—Telmisartan—hypertension	4.56e-06	6.28e-05	CcSEcCtD
Doxazosin—Asthenia—Losartan—hypertension	4.56e-06	6.27e-05	CcSEcCtD
Doxazosin—Headache—Enalapril—hypertension	4.55e-06	6.27e-05	CcSEcCtD
Doxazosin—Pain—Timolol—hypertension	4.55e-06	6.27e-05	CcSEcCtD
Doxazosin—Rash—Telmisartan—hypertension	4.52e-06	6.22e-05	CcSEcCtD
Doxazosin—Dermatitis—Telmisartan—hypertension	4.52e-06	6.22e-05	CcSEcCtD
Doxazosin—Diarrhoea—Furosemide—hypertension	4.5e-06	6.2e-05	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Lisinopril—hypertension	4.5e-06	6.19e-05	CcSEcCtD
Doxazosin—Pruritus—Losartan—hypertension	4.49e-06	6.18e-05	CcSEcCtD
Doxazosin—Headache—Telmisartan—hypertension	4.49e-06	6.18e-05	CcSEcCtD
Doxazosin—Feeling abnormal—Ramipril—hypertension	4.49e-06	6.18e-05	CcSEcCtD
Doxazosin—Dizziness—Perindopril—hypertension	4.48e-06	6.16e-05	CcSEcCtD
Doxazosin—Insomnia—Lisinopril—hypertension	4.47e-06	6.15e-05	CcSEcCtD
Doxazosin—Dizziness—Irbesartan—hypertension	4.46e-06	6.14e-05	CcSEcCtD
Doxazosin—Diarrhoea—Betaxolol—hypertension	4.46e-06	6.14e-05	CcSEcCtD
Doxazosin—Gastrointestinal pain—Ramipril—hypertension	4.45e-06	6.13e-05	CcSEcCtD
Doxazosin—Nausea—Clonidine—hypertension	4.45e-06	6.12e-05	CcSEcCtD
Doxazosin—Paraesthesia—Lisinopril—hypertension	4.43e-06	6.1e-05	CcSEcCtD
Doxazosin—Vomiting—Captopril—hypertension	4.43e-06	6.1e-05	CcSEcCtD
Doxazosin—Dizziness—Hydrochlorothiazide—hypertension	4.43e-06	6.09e-05	CcSEcCtD
Doxazosin—Dyspnoea—Lisinopril—hypertension	4.4e-06	6.06e-05	CcSEcCtD
Doxazosin—Rash—Captopril—hypertension	4.4e-06	6.05e-05	CcSEcCtD
Doxazosin—Dermatitis—Captopril—hypertension	4.39e-06	6.05e-05	CcSEcCtD
Doxazosin—Somnolence—Lisinopril—hypertension	4.39e-06	6.04e-05	CcSEcCtD
Doxazosin—Feeling abnormal—Timolol—hypertension	4.39e-06	6.04e-05	CcSEcCtD
Doxazosin—Headache—Captopril—hypertension	4.37e-06	6.01e-05	CcSEcCtD
Doxazosin—Gastrointestinal pain—Timolol—hypertension	4.35e-06	5.99e-05	CcSEcCtD
Doxazosin—Dizziness—Furosemide—hypertension	4.35e-06	5.99e-05	CcSEcCtD
Doxazosin—Dyspepsia—Lisinopril—hypertension	4.35e-06	5.98e-05	CcSEcCtD
Doxazosin—Diarrhoea—Losartan—hypertension	4.34e-06	5.98e-05	CcSEcCtD
Doxazosin—Nausea—Trandolapril—hypertension	4.34e-06	5.97e-05	CcSEcCtD
Doxazosin—Urticaria—Ramipril—hypertension	4.33e-06	5.95e-05	CcSEcCtD
Doxazosin—Nausea—Enalapril—hypertension	4.32e-06	5.94e-05	CcSEcCtD
Doxazosin—Dizziness—Betaxolol—hypertension	4.31e-06	5.93e-05	CcSEcCtD
Doxazosin—Vomiting—Perindopril—hypertension	4.3e-06	5.92e-05	CcSEcCtD
Doxazosin—Abdominal pain—Ramipril—hypertension	4.3e-06	5.92e-05	CcSEcCtD
Doxazosin—Body temperature increased—Ramipril—hypertension	4.3e-06	5.92e-05	CcSEcCtD
Doxazosin—Decreased appetite—Lisinopril—hypertension	4.29e-06	5.91e-05	CcSEcCtD
Doxazosin—Vomiting—Irbesartan—hypertension	4.29e-06	5.91e-05	CcSEcCtD
Doxazosin—Rash—Perindopril—hypertension	4.27e-06	5.88e-05	CcSEcCtD
Doxazosin—Dermatitis—Perindopril—hypertension	4.26e-06	5.87e-05	CcSEcCtD
Doxazosin—Nausea—Telmisartan—hypertension	4.26e-06	5.86e-05	CcSEcCtD
Doxazosin—Fatigue—Lisinopril—hypertension	4.26e-06	5.86e-05	CcSEcCtD
Doxazosin—Vomiting—Hydrochlorothiazide—hypertension	4.26e-06	5.86e-05	CcSEcCtD
Doxazosin—Rash—Irbesartan—hypertension	4.25e-06	5.86e-05	CcSEcCtD
Doxazosin—Dermatitis—Irbesartan—hypertension	4.25e-06	5.85e-05	CcSEcCtD
Doxazosin—Headache—Perindopril—hypertension	4.24e-06	5.84e-05	CcSEcCtD
Doxazosin—Urticaria—Timolol—hypertension	4.23e-06	5.82e-05	CcSEcCtD
Doxazosin—Headache—Irbesartan—hypertension	4.23e-06	5.82e-05	CcSEcCtD
Doxazosin—Pain—Lisinopril—hypertension	4.22e-06	5.81e-05	CcSEcCtD
Doxazosin—Constipation—Lisinopril—hypertension	4.22e-06	5.81e-05	CcSEcCtD
Doxazosin—Rash—Hydrochlorothiazide—hypertension	4.22e-06	5.81e-05	CcSEcCtD
Doxazosin—Dermatitis—Hydrochlorothiazide—hypertension	4.22e-06	5.8e-05	CcSEcCtD
Doxazosin—Body temperature increased—Timolol—hypertension	4.21e-06	5.79e-05	CcSEcCtD
Doxazosin—Abdominal pain—Timolol—hypertension	4.21e-06	5.79e-05	CcSEcCtD
Doxazosin—Dizziness—Losartan—hypertension	4.2e-06	5.78e-05	CcSEcCtD
Doxazosin—Headache—Hydrochlorothiazide—hypertension	4.19e-06	5.77e-05	CcSEcCtD
Doxazosin—Vomiting—Furosemide—hypertension	4.18e-06	5.76e-05	CcSEcCtD
Doxazosin—Rash—Furosemide—hypertension	4.15e-06	5.71e-05	CcSEcCtD
Doxazosin—Dermatitis—Furosemide—hypertension	4.15e-06	5.71e-05	CcSEcCtD
Doxazosin—Vomiting—Betaxolol—hypertension	4.14e-06	5.7e-05	CcSEcCtD
Doxazosin—Nausea—Captopril—hypertension	4.14e-06	5.7e-05	CcSEcCtD
Doxazosin—Headache—Furosemide—hypertension	4.12e-06	5.67e-05	CcSEcCtD
Doxazosin—Rash—Betaxolol—hypertension	4.11e-06	5.65e-05	CcSEcCtD
Doxazosin—Dermatitis—Betaxolol—hypertension	4.1e-06	5.65e-05	CcSEcCtD
Doxazosin—Headache—Betaxolol—hypertension	4.08e-06	5.62e-05	CcSEcCtD
Doxazosin—Feeling abnormal—Lisinopril—hypertension	4.07e-06	5.6e-05	CcSEcCtD
Doxazosin—Gastrointestinal pain—Lisinopril—hypertension	4.04e-06	5.56e-05	CcSEcCtD
Doxazosin—Vomiting—Losartan—hypertension	4.04e-06	5.56e-05	CcSEcCtD
Doxazosin—Nausea—Perindopril—hypertension	4.02e-06	5.54e-05	CcSEcCtD
Doxazosin—Hypersensitivity—Ramipril—hypertension	4.01e-06	5.52e-05	CcSEcCtD
Doxazosin—Nausea—Irbesartan—hypertension	4.01e-06	5.52e-05	CcSEcCtD
Doxazosin—Rash—Losartan—hypertension	4e-06	5.51e-05	CcSEcCtD
Doxazosin—Dermatitis—Losartan—hypertension	4e-06	5.51e-05	CcSEcCtD
Doxazosin—Headache—Losartan—hypertension	3.98e-06	5.48e-05	CcSEcCtD
Doxazosin—Nausea—Hydrochlorothiazide—hypertension	3.98e-06	5.47e-05	CcSEcCtD
Doxazosin—Urticaria—Lisinopril—hypertension	3.92e-06	5.4e-05	CcSEcCtD
Doxazosin—Hypersensitivity—Timolol—hypertension	3.92e-06	5.4e-05	CcSEcCtD
Doxazosin—Nausea—Furosemide—hypertension	3.91e-06	5.38e-05	CcSEcCtD
Doxazosin—Asthenia—Ramipril—hypertension	3.91e-06	5.38e-05	CcSEcCtD
Doxazosin—Abdominal pain—Lisinopril—hypertension	3.9e-06	5.37e-05	CcSEcCtD
Doxazosin—Body temperature increased—Lisinopril—hypertension	3.9e-06	5.37e-05	CcSEcCtD
Doxazosin—Nausea—Betaxolol—hypertension	3.87e-06	5.33e-05	CcSEcCtD
Doxazosin—Pruritus—Ramipril—hypertension	3.85e-06	5.3e-05	CcSEcCtD
Doxazosin—Asthenia—Timolol—hypertension	3.82e-06	5.26e-05	CcSEcCtD
Doxazosin—Nausea—Losartan—hypertension	3.77e-06	5.19e-05	CcSEcCtD
Doxazosin—Pruritus—Timolol—hypertension	3.77e-06	5.18e-05	CcSEcCtD
Doxazosin—Diarrhoea—Ramipril—hypertension	3.73e-06	5.13e-05	CcSEcCtD
Doxazosin—Diarrhoea—Timolol—hypertension	3.64e-06	5.01e-05	CcSEcCtD
Doxazosin—Hypersensitivity—Lisinopril—hypertension	3.64e-06	5.01e-05	CcSEcCtD
Doxazosin—Dizziness—Ramipril—hypertension	3.6e-06	4.96e-05	CcSEcCtD
Doxazosin—Asthenia—Lisinopril—hypertension	3.54e-06	4.88e-05	CcSEcCtD
Doxazosin—Dizziness—Timolol—hypertension	3.52e-06	4.84e-05	CcSEcCtD
Doxazosin—Pruritus—Lisinopril—hypertension	3.49e-06	4.81e-05	CcSEcCtD
Doxazosin—Vomiting—Ramipril—hypertension	3.46e-06	4.77e-05	CcSEcCtD
Doxazosin—Rash—Ramipril—hypertension	3.43e-06	4.73e-05	CcSEcCtD
Doxazosin—Dermatitis—Ramipril—hypertension	3.43e-06	4.72e-05	CcSEcCtD
Doxazosin—Headache—Ramipril—hypertension	3.41e-06	4.7e-05	CcSEcCtD
Doxazosin—Vomiting—Timolol—hypertension	3.38e-06	4.66e-05	CcSEcCtD
Doxazosin—Diarrhoea—Lisinopril—hypertension	3.38e-06	4.65e-05	CcSEcCtD
Doxazosin—Rash—Timolol—hypertension	3.36e-06	4.62e-05	CcSEcCtD
Doxazosin—Dermatitis—Timolol—hypertension	3.35e-06	4.62e-05	CcSEcCtD
Doxazosin—Headache—Timolol—hypertension	3.33e-06	4.59e-05	CcSEcCtD
Doxazosin—Dizziness—Lisinopril—hypertension	3.27e-06	4.49e-05	CcSEcCtD
Doxazosin—Nausea—Ramipril—hypertension	3.23e-06	4.45e-05	CcSEcCtD
Doxazosin—Nausea—Timolol—hypertension	3.16e-06	4.35e-05	CcSEcCtD
Doxazosin—Vomiting—Lisinopril—hypertension	3.14e-06	4.32e-05	CcSEcCtD
Doxazosin—Rash—Lisinopril—hypertension	3.11e-06	4.29e-05	CcSEcCtD
Doxazosin—Dermatitis—Lisinopril—hypertension	3.11e-06	4.28e-05	CcSEcCtD
Doxazosin—Headache—Lisinopril—hypertension	3.09e-06	4.26e-05	CcSEcCtD
Doxazosin—Nausea—Lisinopril—hypertension	2.93e-06	4.04e-05	CcSEcCtD
Doxazosin—ADRA1B—Signaling Pathways—NOTCH1—hypertension	6.7e-07	1.98e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—STK11—hypertension	6.68e-07	1.98e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CYP19A1—hypertension	6.68e-07	1.98e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PPARGC1A—hypertension	6.65e-07	1.97e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GNB3—hypertension	6.65e-07	1.97e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—FGF2—hypertension	6.65e-07	1.97e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—HMOX1—hypertension	6.62e-07	1.96e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—RHOA—hypertension	6.62e-07	1.96e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HIF1A—hypertension	6.61e-07	1.96e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PRKCD—hypertension	6.59e-07	1.95e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CCR5—hypertension	6.59e-07	1.95e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—COMT—hypertension	6.59e-07	1.95e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AGT—hypertension	6.58e-07	1.95e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PIK3R1—hypertension	6.55e-07	1.94e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—NOS3—hypertension	6.55e-07	1.94e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CAT—hypertension	6.54e-07	1.94e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hypertension	6.5e-07	1.92e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GNB3—hypertension	6.49e-07	1.92e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PPARGC1A—hypertension	6.49e-07	1.92e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GNAS—hypertension	6.48e-07	1.92e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CALM1—hypertension	6.47e-07	1.92e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—HMOX1—hypertension	6.46e-07	1.91e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—LEP—hypertension	6.45e-07	1.91e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—APOE—hypertension	6.45e-07	1.91e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HTR2A—hypertension	6.45e-07	1.91e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—C3—hypertension	6.44e-07	1.91e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CAV1—hypertension	6.39e-07	1.89e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CAT—hypertension	6.38e-07	1.89e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—APOA1—hypertension	6.38e-07	1.89e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—APOB—hypertension	6.34e-07	1.88e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GNAS—hypertension	6.32e-07	1.87e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—KDR—hypertension	6.32e-07	1.87e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PDGFB—hypertension	6.27e-07	1.86e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PPARG—hypertension	6.24e-07	1.85e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—POMC—hypertension	6.24e-07	1.85e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—FGFR1—hypertension	6.23e-07	1.85e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—COMT—hypertension	6.21e-07	1.84e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—INS—hypertension	6.2e-07	1.84e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—APOB—hypertension	6.19e-07	1.83e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GSTM1—hypertension	6.17e-07	1.83e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—RELA—hypertension	6.17e-07	1.83e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—POMC—hypertension	6.16e-07	1.82e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HIF1A—hypertension	6.14e-07	1.82e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—INS—hypertension	6.12e-07	1.81e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GNB3—hypertension	6.12e-07	1.81e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PPARGC1A—hypertension	6.12e-07	1.81e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AGT—hypertension	6.12e-07	1.81e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CCL2—hypertension	6.1e-07	1.81e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—HMOX1—hypertension	6.09e-07	1.8e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—AKT1—hypertension	6.09e-07	1.8e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—F2—hypertension	6.08e-07	1.8e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PRKCB—hypertension	6.08e-07	1.8e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—FN1—hypertension	6.08e-07	1.8e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—LPL—hypertension	6.06e-07	1.79e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MTOR—hypertension	6.05e-07	1.79e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GSTM1—hypertension	6.02e-07	1.78e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CALM1—hypertension	6.01e-07	1.78e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CAT—hypertension	6.01e-07	1.78e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IGF1—hypertension	6e-07	1.78e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—AKT2—hypertension	6e-07	1.78e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—APOE—hypertension	5.99e-07	1.77e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—LEP—hypertension	5.99e-07	1.77e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—EGFR—hypertension	5.97e-07	1.77e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GNAS—hypertension	5.96e-07	1.76e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NOTCH1—hypertension	5.95e-07	1.76e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CAV1—hypertension	5.94e-07	1.76e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ADCY5—hypertension	5.93e-07	1.76e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—APOA1—hypertension	5.92e-07	1.75e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—LPL—hypertension	5.91e-07	1.75e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GPX1—hypertension	5.91e-07	1.75e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—KDR—hypertension	5.87e-07	1.74e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PRKCA—hypertension	5.85e-07	1.73e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CYP1A1—hypertension	5.85e-07	1.73e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—APOB—hypertension	5.84e-07	1.73e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CXCL8—hypertension	5.81e-07	1.72e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ADCY5—hypertension	5.79e-07	1.71e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GPX1—hypertension	5.77e-07	1.71e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CD36—hypertension	5.76e-07	1.7e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PRKCA—hypertension	5.71e-07	1.69e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CYP1A1—hypertension	5.71e-07	1.69e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—SERPINE1—hypertension	5.7e-07	1.69e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GSTM1—hypertension	5.68e-07	1.68e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PRKCB—hypertension	5.65e-07	1.67e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—F2—hypertension	5.65e-07	1.67e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—FN1—hypertension	5.65e-07	1.67e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CD36—hypertension	5.62e-07	1.66e-05	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—AKT1—hypertension	5.62e-07	1.66e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—ALB—hypertension	5.61e-07	1.66e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—LPL—hypertension	5.57e-07	1.65e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—POMC—hypertension	5.54e-07	1.64e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NOTCH1—hypertension	5.53e-07	1.64e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—IL6—hypertension	5.53e-07	1.64e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—FGF2—hypertension	5.52e-07	1.63e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—INS—hypertension	5.51e-07	1.63e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—RHOA—hypertension	5.5e-07	1.63e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ADCY5—hypertension	5.45e-07	1.62e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—MTHFR—hypertension	5.45e-07	1.62e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PIK3R1—hypertension	5.44e-07	1.61e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—NOS3—hypertension	5.44e-07	1.61e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GPX1—hypertension	5.44e-07	1.61e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CCL2—hypertension	5.42e-07	1.61e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CYP1A1—hypertension	5.38e-07	1.59e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PRKCA—hypertension	5.38e-07	1.59e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—NOS3—hypertension	5.37e-07	1.59e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PIK3R1—hypertension	5.37e-07	1.59e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PPARA—hypertension	5.35e-07	1.58e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IGF1—hypertension	5.33e-07	1.58e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AKT2—hypertension	5.33e-07	1.58e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—MTHFR—hypertension	5.32e-07	1.58e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—EGFR—hypertension	5.3e-07	1.57e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CD36—hypertension	5.29e-07	1.57e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MMP9—hypertension	5.26e-07	1.56e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CDKN1A—hypertension	5.24e-07	1.55e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PTEN—hypertension	5.23e-07	1.55e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PPARA—hypertension	5.22e-07	1.55e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—AGT—hypertension	5.18e-07	1.53e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—POMC—hypertension	5.15e-07	1.52e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—RELA—hypertension	5.12e-07	1.52e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—INS—hypertension	5.12e-07	1.52e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MAPK8—hypertension	5.11e-07	1.51e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—AKT1—hypertension	5.1e-07	1.51e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CALM1—hypertension	5.1e-07	1.51e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—APOE—hypertension	5.08e-07	1.5e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SERPINE1—hypertension	5.06e-07	1.5e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—AGT—hypertension	5.06e-07	1.5e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CCL2—hypertension	5.04e-07	1.49e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CAV1—hypertension	5.03e-07	1.49e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MTOR—hypertension	5.02e-07	1.49e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—APOA1—hypertension	5.02e-07	1.49e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—MTHFR—hypertension	5.02e-07	1.49e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—EP300—hypertension	4.99e-07	1.48e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CALM1—hypertension	4.97e-07	1.47e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—APOE—hypertension	4.96e-07	1.47e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IGF1—hypertension	4.95e-07	1.47e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AKT2—hypertension	4.95e-07	1.47e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—EGFR—hypertension	4.93e-07	1.46e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PPARA—hypertension	4.92e-07	1.46e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PTGS2—hypertension	4.91e-07	1.45e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CAV1—hypertension	4.91e-07	1.45e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—FGF2—hypertension	4.9e-07	1.45e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—APOA1—hypertension	4.9e-07	1.45e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—RHOA—hypertension	4.88e-07	1.45e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—SRC—hypertension	4.85e-07	1.44e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PIK3R1—hypertension	4.83e-07	1.43e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NOS3—hypertension	4.83e-07	1.43e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CXCL8—hypertension	4.83e-07	1.43e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—AGT—hypertension	4.77e-07	1.41e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—VEGFA—hypertension	4.72e-07	1.4e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SERPINE1—hypertension	4.7e-07	1.39e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CALM1—hypertension	4.69e-07	1.39e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—APOE—hypertension	4.67e-07	1.38e-05	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—AKT1—hypertension	4.66e-07	1.38e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CAV1—hypertension	4.63e-07	1.37e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—APOA1—hypertension	4.62e-07	1.37e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—IL6—hypertension	4.59e-07	1.36e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—FGF2—hypertension	4.55e-07	1.35e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—RELA—hypertension	4.55e-07	1.35e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—RHOA—hypertension	4.54e-07	1.34e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PIK3R1—hypertension	4.49e-07	1.33e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NOS3—hypertension	4.49e-07	1.33e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MTOR—hypertension	4.46e-07	1.32e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PPARG—hypertension	4.42e-07	1.31e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MMP9—hypertension	4.36e-07	1.29e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—POMC—hypertension	4.36e-07	1.29e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CDKN1A—hypertension	4.35e-07	1.29e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MYC—hypertension	4.34e-07	1.29e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PTEN—hypertension	4.34e-07	1.28e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—INS—hypertension	4.34e-07	1.28e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TGFB1—hypertension	4.33e-07	1.28e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PPARG—hypertension	4.32e-07	1.28e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CXCL8—hypertension	4.29e-07	1.27e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PTEN—hypertension	4.28e-07	1.27e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—POMC—hypertension	4.26e-07	1.26e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—EGFR—hypertension	4.25e-07	1.26e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MAPK8—hypertension	4.24e-07	1.26e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—INS—hypertension	4.23e-07	1.25e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—AKT1—hypertension	4.23e-07	1.25e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—RELA—hypertension	4.23e-07	1.25e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MTOR—hypertension	4.14e-07	1.23e-05	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—AKT1—hypertension	4.14e-07	1.23e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—EP300—hypertension	4.14e-07	1.23e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—EP300—hypertension	4.08e-07	1.21e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—IL6—hypertension	4.08e-07	1.21e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PPARG—hypertension	4.07e-07	1.2e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—SRC—hypertension	4.02e-07	1.19e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—POMC—hypertension	4.01e-07	1.19e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—INS—hypertension	3.99e-07	1.18e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CXCL8—hypertension	3.98e-07	1.18e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ALB—hypertension	3.98e-07	1.18e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—VEGFA—hypertension	3.92e-07	1.16e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ALB—hypertension	3.88e-07	1.15e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MMP9—hypertension	3.88e-07	1.15e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CDKN1A—hypertension	3.86e-07	1.14e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PTEN—hypertension	3.85e-07	1.14e-05	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—AKT1—hypertension	3.85e-07	1.14e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PIK3R1—hypertension	3.8e-07	1.13e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—NOS3—hypertension	3.8e-07	1.13e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—IL6—hypertension	3.79e-07	1.12e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MAPK8—hypertension	3.77e-07	1.12e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—AKT1—hypertension	3.76e-07	1.11e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PIK3R1—hypertension	3.71e-07	1.1e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—NOS3—hypertension	3.71e-07	1.1e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—EP300—hypertension	3.68e-07	1.09e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ALB—hypertension	3.66e-07	1.08e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MYC—hypertension	3.61e-07	1.07e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MMP9—hypertension	3.6e-07	1.07e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TGFB1—hypertension	3.6e-07	1.07e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CDKN1A—hypertension	3.59e-07	1.06e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PTEN—hypertension	3.58e-07	1.06e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SRC—hypertension	3.57e-07	1.06e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TP53—hypertension	3.57e-07	1.06e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—EGFR—hypertension	3.53e-07	1.04e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MAPK8—hypertension	3.5e-07	1.04e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—NOS3—hypertension	3.5e-07	1.04e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PIK3R1—hypertension	3.5e-07	1.04e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—AKT1—hypertension	3.49e-07	1.03e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—VEGFA—hypertension	3.48e-07	1.03e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PTGS2—hypertension	3.48e-07	1.03e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—EP300—hypertension	3.42e-07	1.01e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PTGS2—hypertension	3.4e-07	1.01e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SRC—hypertension	3.32e-07	9.83e-06	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IL6—hypertension	3.27e-07	9.67e-06	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—VEGFA—hypertension	3.23e-07	9.58e-06	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MYC—hypertension	3.2e-07	9.48e-06	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PTGS2—hypertension	3.2e-07	9.48e-06	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TGFB1—hypertension	3.2e-07	9.46e-06	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—EGFR—hypertension	3.13e-07	9.28e-06	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PTEN—hypertension	3.03e-07	8.98e-06	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—AKT1—hypertension	3.01e-07	8.92e-06	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MYC—hypertension	2.98e-07	8.81e-06	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TGFB1—hypertension	2.97e-07	8.79e-06	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PTEN—hypertension	2.96e-07	8.77e-06	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TP53—hypertension	2.96e-07	8.77e-06	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—EGFR—hypertension	2.91e-07	8.62e-06	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—EP300—hypertension	2.89e-07	8.57e-06	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—EP300—hypertension	2.82e-07	8.36e-06	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PTEN—hypertension	2.79e-07	8.26e-06	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IL6—hypertension	2.71e-07	8.03e-06	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—EP300—hypertension	2.66e-07	7.88e-06	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TP53—hypertension	2.63e-07	7.79e-06	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—AKT1—hypertension	2.5e-07	7.41e-06	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—AKT1—hypertension	2.47e-07	7.31e-06	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TP53—hypertension	2.44e-07	7.24e-06	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IL6—hypertension	2.41e-07	7.13e-06	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IL6—hypertension	2.24e-07	6.62e-06	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AKT1—hypertension	2.22e-07	6.58e-06	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AKT1—hypertension	2.06e-07	6.11e-06	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—AKT1—hypertension	1.75e-07	5.18e-06	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—AKT1—hypertension	1.71e-07	5.05e-06	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—AKT1—hypertension	1.61e-07	4.76e-06	CbGpPWpGaD
